HomeAPRE • NASDAQ
add
Aprea Therapeutics Inc
Previous close
$1.26
Day range
$1.11 - $1.26
Year range
$1.08 - $5.00
Market cap
7.07M USD
Avg Volume
114.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 1.85K | -99.48% |
Operating expense | 1.48M | -7.78% |
Net income | -2.97M | 21.44% |
Net profit margin | -160.84K | -14,974.62% |
Earnings per share | -0.47 | 26.56% |
EBITDA | -3.11M | 23.94% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.72M | -47.74% |
Total assets | 14.32M | -46.75% |
Total liabilities | 2.68M | -26.26% |
Total equity | 11.64M | — |
Shares outstanding | 6.31M | — |
Price to book | 0.69 | — |
Return on assets | -49.28% | — |
Return on capital | -60.46% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -2.97M | 21.44% |
Cash from operations | -3.17M | -28.48% |
Cash from investing | — | — |
Cash from financing | 357.94K | 31,090.48% |
Net change in cash | -2.81M | -15.10% |
Free cash flow | -2.16M | -68.43% |
About
Website
Employees
8
